electroCore Receives FDA Emergency Use Authorization for use of gammaCore Sapphire CV For COVID-19 Treatment

One of the symptoms of COVID-19 is respiratory problems, and people with asthma are badly affected by the disease as it can make breathing even more difficult. Now, electroCore, a commercial-stage bioelectronic medicine company, announced that the FDA has issued an Emergency Use Authorization (EUA) authorizing the use of gammaCore Sapphire CV non-invasive vagus nerve […]

To access this post, you must purchase Free Subscription, Premium Abo or Premium Abo (6 months).

from Wearable Technologies https://ift.tt/30Zogrs